Weekly shot could free patients from daily calcium pills
NCT ID NCT06465108
Summary
This study tested a new weekly injection called MBX 2109 for adults with hypoparathyroidism, a condition where the body struggles to control calcium levels. The goal was to see if this hormone replacement could safely maintain normal calcium without requiring high doses of daily vitamin D and calcium supplements. Researchers measured whether patients could keep their calcium in a healthy range while significantly reducing their daily pill burden.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOPARATHYROIDISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
MBX Biosciences Investigational Site
Sacramento, California, 95817, United States
-
MBX Biosciences Investigational Site
Jacksonville, Florida, 32204, United States
-
MBX Biosciences Investigational Site
Jacksonville, Florida, 32216, United States
-
MBX Biosciences Investigational Site
Miami, Florida, 33033, United States
-
MBX Biosciences Investigational Site
Macon, Georgia, 31210, United States
-
MBX Biosciences Investigational Site
Chicago, Illinois, 60611, United States
-
MBX Biosciences Investigational Site
Chicago, Illinois, 60637, United States
-
MBX Biosciences Investigational Site
Jackson, Mississippi, 39202, United States
-
MBX Biosciences Investigational Site
St Louis, Missouri, 63110, United States
-
MBX Biosciences Investigational Site
Omaha, Nebraska, 68198, United States
-
MBX Biosciences Investigational Site
Las Vegas, Nevada, 89148, United States
-
MBX Biosciences Investigational Site
Reno, Nevada, 89511, United States
-
MBX Biosciences Investigational Site
Albany, New York, 12203, United States
-
MBX Biosciences Investigational Site
Great Neck, New York, 10021, United States
-
MBX Biosciences Investigational Site
New York, New York, 10032, United States
-
MBX Biosciences Investigational Site
The Bronx, New York, 10467, United States
-
MBX Biosciences Investigational Site
Greenville, North Carolina, 27834, United States
-
MBX Biosciences Investigational Site
Cleveland, Ohio, 44195, United States
-
MBX Biosciences Investigational Site
Columbus, Ohio, 43201, United States
-
MBX Biosciences Investigational Site
Philadelphia, Pennsylvania, 19107, United States
-
MBX Biosciences Investigational Site
Dallas, Texas, 75208, United States
-
MBX Biosciences Investigational Site
El Paso, Texas, 79935, United States
-
MBX Biosciences Investigational Site
Fort Worth, Texas, 76132, United States
-
MBX Biosciences Investigational Site
Round Rock, Texas, 78681, United States
-
MBX Biosciences Investigational Site
San Antonio, Texas, 78231, United States
-
MBX Biosciences Investigational Site
Weslaco, Texas, 78596, United States
-
MBX Biosciences Investigational Site
Madison, Wisconsin, 53705, United States
-
MBX Biosciences Investigational Site
CABA, Buenos Aires, C1012AAR, Argentina
-
MBX Biosciences Investigational Site
CABA, Buenos Aires, C1425AGC, Argentina
-
MBX Biosciences Investigational Site
Río Cuarto, Córdoba Province, X5800AEV, Argentina
-
MBX Biosciences Investigational Site
Córdoba, X5000AAW, Argentina
-
MBX Biosciences Investigational Site
San Miguel de Tucumán, T4000IEH, Argentina
-
MBX Biosciences Investigational Site
Samsun, 55270, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.